News

Tri-County Financial Group Sees Impressive Growth in 2025

Tri-County Financial Group Sees Impressive Growth in 2025

Diving into the Numbers: What’s Really Happening?

The recent financial report from Tri-County Financial Group, Inc. really kicks the doors open on how robust their performance is. You can’t ignore the solid figures; net income shot up to $3.9 million for Q4 of 2025, climbing from $2.4 million the previous year. That’s a jump to $1.64 per share from just a buck—impressive stuff if you ask me.

Full Year Review: Growth Across the Board

Let’s pull back the lens. For the entire 2025 fiscal year, they reported a net income of $13.7 million—up a pretty outrageous 32% over 2024’s $10.4 million. You know what that kind of growth means for investors? Potential. It spells confidence, and confidence can drive share prices higher.

Net interest income rose too, climbing 21% to $13.2 million for the fourth quarter—compared to just $10.9 million in Q4 of 2024. When your bank can show these kinds of numbers, it speaks volumes about how they’re managing their loans and interest rates. Apply some pressure on your local competition and see who’s left standing.

Loan Growth: A Mixed Bag

Now, let’s not gloss over everything with rose-colored glasses. Total loans did creep up $42.6 million, or about 3%, landing at $1.33 billion by year-end. But nonperforming loans also ticked up as a percentage, now at 0.43%. Not alarm bells ringing, but it's a note-worthy uptick—something to keep an eye on as we swing into 2026.

Deposits and Their Competition

We’re continuing our deposit growth strategies in a competitive market.

Kirk Ross, the President and CEO, sure seems confident, and why not? Deposits shot up $30.6 million year-on-year, totaling $1.304 billion. However, the truth hurts; brokered deposits made up some of this increase. Previously at $49.3 million now down to $44.9 million, it’s clear they’re in a dog-eat-dog market. Deposits are essential—they’re the lifeblood that keeps the bank moving.

Investment Portfolio: Keeping an Eye on the Market

Their investments add another layer of caution. The entire portfolio consists of debt securities available-for-sale, which lets them report unrealized gains and losses on the balance sheet—a strategy that could cushion them against market volatility. This portfolio did increase 7% to $154.2 million, but what's the real risk here? Investors need to ask whether they’re getting enough bang for their buck or if they’re just riding waves of uncertainty.

On Dividends and Shareholder Incentives

Let’s not skip over the cherry on top. On December 9, 2025, Tri-County declared a dividend of $0.25 per share, payable in early January to shareholders who registered by the year's end. For a bank like TYFG, returning capital to shareholders is key, and it signals they’re not just hoarding cash—they’re interested in keeping investors happy and engaged.

Looking Ahead: Is the Future Bright?

What’s next for Tri-County? There’s a mixed bag out there—interest rates are in flux, and competition isn’t just going to roll over because they had a good year. If they can continue executing smart loan strategies, watch out for further growth. A Tier 1 leverage ratio of over 10% shows they’re not overextended, but will they adapt to the changing financial landscape?

Final Lamentations

Investors would be wise to keep an eye on some of the potential headwinds they face, especially if inflation keeps biting and the economic environment tightens. For all their promising growth in 2025, the narrative can shift overnight. At OTCQX: TYFG, there's both opportunity and risk packed in these current gains that are worth mulling over.

As for the stock itself? Well, there’s a solid foundation here but tread carefully. Keep your ear to the ground; this financial institution might be poised for more than just growth in its backyard.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 11

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 19

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

America's Car-Mart Secures $300 Million Loan for Growth

Updated Category News Views 255

America's Car-Mart Secures Funding for Future Growth America's Car-Mart, Inc. (NASDAQ: CRMT), a leading automotive retailer, has taken a strategic step by closing a significant five-year, $300 million term loan. This loan, managed by the seasoned professionals at Silver Point Capital, L.P., aims to enhance the company’s capital structure and support its long-term growth...

Continue Reading
IASO Bio's Breakthrough Drug Application Acceptance in Singapore

Updated Category News Views 251

IASO Bio’s Major Step Forward with New Drug Application IASO Biotherapeutics, a pioneering biopharmaceutical company dedicated to the advancement of innovative cell therapies and biologics, has reached a significant milestone. The Singapore Health Sciences Authority (HSA) has officially accepted the New Drug Application (NDA) for Equecabtagene Autoleucel, known as...

Continue Reading
Creating Community Leaders: National Heritage Academies and United Way

Updated Category News Views 150

Empowering Students to Make a Difference The student-led organization is providing career opportunities while connecting with the community. National Heritage Academies® (NHA) is thrilled to celebrate its collaboration with United Way through the Student United Way program. This initiative equips high school students with essential tools and opportunities to enact...

Continue Reading
Future Growth of Augmented and Virtual Reality Technologies

Updated Category News Views 259

Exploring the Growth of Augmented Reality and Virtual Reality Market The global market for Augmented Reality (AR) and Virtual Reality (VR) is on the rise, with expectations of substantial growth over the next few years. Analysts estimate that this sector will expand by approximately USD 442.99 billion between 2024 and 2028. The compound annual growth rate (CAGR) for this...

Continue Reading
ImmVira Launches Innovative Exosome, Transforming Cosmetics

Updated Category News Views 407

ImmVira Leads the Way with Groundbreaking Exosome Technology In a remarkable advancement for the cosmetic industry, ImmVira Group has announced its innovative product, MVR-EX103, an engineered exosome specifically developed for treating superficial skin depressions. This development marks a pivotal moment, as it has successfully acquired the International Nomenclature...

Continue Reading